Mast Cell Activation Syndrome clinical trials

Explore recruiting mast cell activation syndrome clinical trials.

Recruiting mast cell activation syndrome studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Mast Cell Activation Syndrome trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2 Multicenter Study of TL-895 in Subjects with Myelofibrosis, Indolent Systemic Mastocytosis, Monoclonal Mast Cell Activation Syndrome, or Non-Monoclonal Mast Cell Activation Syndrome

Germany, Italy, Spain, Belgium, Bulgaria, France +3 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A 24-week, multicenter, randomized, double blind, placebo-controlled, dose-range finding phase II study to compare efficacy and safety of oral masitinib to placebo in treatment of patients with severe mast cell activation syndrome (MCAS) with handicap unresponsive to optimal symptomatic treatment

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Mast Cell Activation Syndrome trials by city

Mast Cell Activation Syndrome in Toronto Mast Cell Activation Syndrome in Vancouver Mast Cell Activation Syndrome in Montreal Mast Cell Activation Syndrome in Calgary Mast Cell Activation Syndrome in Edmonton Mast Cell Activation Syndrome in Ottawa Mast Cell Activation Syndrome in Winnipeg Mast Cell Activation Syndrome in Quebec City Mast Cell Activation Syndrome in Hamilton Mast Cell Activation Syndrome in Kitchener Mast Cell Activation Syndrome in London Mast Cell Activation Syndrome in Halifax Mast Cell Activation Syndrome in New York Mast Cell Activation Syndrome in Los Angeles Mast Cell Activation Syndrome in Chicago Mast Cell Activation Syndrome in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease